Nautilus Biotechnology (NAUT) Interest Expenses (2020 - 2026)

Nautilus Biotechnology (NAUT) has 7 years of Interest Expenses data on file, last reported at $27.0 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses rose 1402.44% year-over-year to $27.0 million; the trailing twelve-month figure through Mar 2026 stood at $27.0 million (up 2997.82% YoY), and the FY2025 full-year result was $93.4 million, up 19.16% from the prior year.
• Interest Expenses advanced to $27.0 million in Q1 2026, from -$5.4 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $49.8 million in Q2 2023 to a low of -$5.4 million in Q4 2025.
• A 5-year average of $21.1 million and a median of $27.0 million in 2026 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses slumped 546.33% in 2022 and jumped 1402.44% in 2026, its largest moves.
• Tracing NAUT's Interest Expenses over 5 years: stood at -$2.7 million in 2022, then plunged by 65.31% to -$4.4 million in 2023, then jumped by 140.66% to $1.8 million in 2024, then slumped by 398.22% to -$5.4 million in 2025, then soared by 603.8% to $27.0 million in 2026.
• Business Quant data shows NAUT's Interest Expenses at $27.0 million in Q1 2026, -$5.4 million in Q4 2025, and $34.0 million in Q3 2025.